Gleason Group, Inc.

Position in MRK — Merck & Co., Inc.

CIK 1822632 PROSPECT, KY

Position in MRK

as of Jun 30, 2026 · filed Jul 13, 2026 Compact

Position Value

$115,521

+$31,800 QoQ

Shares Held

899

+29.2% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.21%

of 13F equity value

Holder Rank

#3,578

of 3,769 holders

Holding Since

Mar 2023

14 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Gleason Group, Inc. holds $4,846,851 across 10 Drug Manufacturers - General names. MRK ranks #5 (2.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	6,605	$1,677,471
2	LLY	ELI LILLY & Co	1,368	$1,640,820
3	GILD	Gilead Sciences, Inc.	9,418	$1,189,870
4	AMGN	Amgen Inc	389	$140,864
5	MRK	Merck & Co., Inc. This page	899	$115,521
6	ABBV	AbbVie Inc.	220	$55,360
7	NVS	Novartis AG	62	$9,716
8	AZN	Astrazeneca PLC	40	$7,584

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$115,521	899	+29.2%	Shares	Sole	2026-07-13
2026-03-31	$83,721	696	+0.7%	Shares	Sole	2026-05-04
2025-12-31	$72,734	691	+4.9%	Shares	Sole	2026-01-15
2025-09-30	$55,309	659	+3.6%	Shares	Sole	2025-10-16
2025-06-30	$50,345	636	+1.0%	Shares	Sole	2025-07-17
2025-03-31	$56,548	630	+0.8%	Shares	Sole	2025-04-11
2024-12-31	$62,175	625	+0.6%	Shares	Sole	2025-01-13
2024-09-30	$70,520	621	+0.6%	Shares	Sole	2024-10-15
2024-06-30	$76,384	617	+0.5%	Shares	Sole	2024-07-12
2024-03-31	$81,017	614	+0.7%	Shares	Sole	2024-04-12
2023-12-31	$66,502	610	+0.8%	Shares	Sole	2024-01-19
2023-09-30	$62,284	605	+0.7%	Shares	Sole	2023-10-12
2023-06-30	$69,349	601	+200.5%	Shares	Sole	2023-07-20
2023-03-31	$21,278	200	—	Shares	Sole	2023-04-14
No filing history on record for this holder in this stock.